switching between tirzepatide and semaglutide to Can You Switch From Tirzepatide

Compounded medications, when prescribed, are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality

Individuals with minimal weight to lose (BMI under 27 kg/m without comorbidities) do not meet clinical criteria for pharmacological weight loss treatment

Always consult your healthcare provider before starting any new treatment.

Becker's ASC

Trial objective and outcomes The objective of this trial was to determine whether a 3-week treatment with the GLP-1 RA dulaglutide compared with placebo reduces fluid intake in patients with primary polydipsia

Like all prescription medicines, semaglutide tablets can cause side effects , most commonly affecting the digestive system, particularly during the early stages of treatment or after a dose increase